Close
Novotech
Jabsco PureFlo 21 Single Use

News

Dainippon Sumitomo Pharma signs pact to acquire US biotech company Boston Biomedical

Dainippon Sumitomo Pharma Co., Ltd has reached an agreement to acquire Norwood, Massachusetts-based biotechnology company, Boston Biomedical Inc. Under the terms of the agreement, DSP will make an upfront payment of US$ 200 million to...

Inclinix partners with JSW for European enrolment support

Inclinix, a US-based contract research organisation (CRO) that provides customised solutions for patient enrolment to Phase I-IV clinical trials, has raised its profile in Eastern and Western Europe through a formal strategic partnership with JSW Life Sciences, a...

KCCI seeks leniency for pharma industry

The Karachi Chamber of Commerce & Industry (KCCI) has expressed discontentment on alleged closure of pharmaceutical industry in the city in the wake of deaths in PIC Lahore due to drug reaction. In a...

New suppliers to ease 2 cancer drug shortages

Federal regulators said Tuesday that they've approved new suppliers for two crucial cancer drugs, easing critical shortages - at least for the time being - that have patients worried about missing life-saving treatments. The Food and...

Bristol-Myers Squibb Foundation Announces Grants Focused on Prevention, Diagnosis and Care of Hepatitis B and Hepatitis C in Asia

The Bristol-Myers Squibb Foundation has awarded three new grants to improve prevention, diagnosis and care of hepatitis B and hepatitis C in China and India as part of its Delivering Hope™: Awareness, Prevention and Care umbrella program which is...

Bayer signs agreement to buy animal health business from KMG Chemicals

Bayer HealthCare, a subgroup of Bayer AG, has signed an agreement to acquire the animal health business from Texas based KMG Chemicals Inc. for executing its strategy to strengthen animal health portfolio. With a wide variety...

US FDA accepts Santarus’ Uceris NDA for induction of remission of active ulcerative colitis

The US Food and Drug Administration has accepted for filing the Santarus Inc.'s New Drug Application for Uceris tablets 9 mg. Pursuant to Prescription Drug User Fee Act guidelines, Santarus expects the FDA will complete its review or otherwise...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »